Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2010 April;51(2) > The Journal of Cardiovascular Surgery 2010 April;51(2):157-68

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632


eTOC

 

REVIEWS  ADVANCES IN THORACIC ENDOGRAFTING


The Journal of Cardiovascular Surgery 2010 April;51(2):157-68

language: English

Comparison of CE approved TEVAR devices

Gawenda M., Brunkwall J.

Department of Vascular Surgery, University of Cologne, Cologne, Germany


PDF  


The indications for endovascular therapy of thoracic aortic pathologies are expanding. The complexity of cases is increasing. The individual anatomy and pathology of the thoracic aorta alone and in combination create specific difficulties in stent graft delivery, deployment, and fixation. Graft design has evolved, and several new iterations of stent grafts have been introduced into clinical practice. The assessment of these new grafts is difficult, due to the changing indications for their use and a lack of large-scale clinical trials. Currently, a number of thoracic stent graft devices are available in Europe. Variable amounts of clinical data are available to support their use.

top of page

Publication History

Cite this article as

Corresponding author e-mail

michael.gawenda@uk-koeln.de